Evidence map›Paper›PMID 36311877›Full record

ArticleNeuroscience and behavioral physiology2022

Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.

M V Putilina, Z Yu Mutovina, O V Kurushina, D M Khalilova, E N Saverskaya, S B Stepanova, M A Khoreva, A S Starikov

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuroscience and behavioral physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 2 countries.

M V PutilinaPirogov Russian National Research Medical University, Russian Ministry of Health, Moscow, Russia.
Z Yu MutovinaCity Clinical Hospital No. 52, Moscow Health Department, Moscow, Russia.
O V KurushinaVolgograd State Medical University, Russian Ministry of Health, Volgograd, Russia.
D M KhalilovaAzerbaijan State Medical University, Baku, Azerbaijan.
E N SaverskayaMoscow State University of Food Production, Moscow, Russia.
S B StepanovaSouth Ural State Medical University, Russian Ministry of Health, Chelyabinsk, Russia.
M A KhorevaAltai State Medical University, Russian Ministry of Health, Barnaul, Russia.
A S StarikovPitirim Sorokin Syktyvkar State University, Syktyvkar, Russia.
Altai State Medical University · RUAzerbaijan Medical University · AZChelyabinsk State Medical Academy · RUCity Clinical Hospital · RUMinistry of Health of the Russian Federation · RUMoscow State University of Food Production · RUSyktyvkar State University · RUVolgograd State Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cognitive impairmentCortexinCOVID-19fatigueolfactory impairmentpostcovid syndromeprevalenceSARS-CoV-2

Identifiers

PMID36311877
PMCPMC9596337
OpenAlexW4307573318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.